Nyormoi O, Wang Z, Doan D, Ruiz M, McConkey D, Bar-Eli M
Department of Cancer Biology, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
Mol Cell Biol. 2001 Aug;21(15):4856-67. doi: 10.1128/MCB.21.15.4856-4867.2001.
Several reports have linked activating protein 2alpha (AP-2alpha) to apoptosis, leading us to hypothesize that AP-2alpha is a substrate for caspases. We tested this hypothesis by examining the effects of tumor necrosis factor alpha (TNF-alpha) on the expression of AP-2 in breast cancer cells. Here, we provide evidence that TNF-alpha downregulates AP-2alpha and AP-2gamma expression posttranscriptionally during TNF-alpha-induced apoptosis. Both a general caspase antagonist (zVADfmk) and a caspase 6-preferred antagonist (zVEIDfmk) inhibited TNF-alpha-induced apoptosis and AP-2alpha downregulation. In vivo tests showed that AP-2alpha was cleaved by caspases ahead of the DNA fragmentation phase of apoptosis. Recombinant caspase 6 cleaved AP-2alpha preferentially, although caspases 1 and 3 also cleaved it, albeit at 50-fold or higher concentrations. Activated caspase 6 was detected in TNF-alpha-treated cells, thus confirming its involvement in AP-2alpha cleavage. All three caspases cleaved AP-2alpha at asp(19) of the sequence asp-arg-his-asp (DRHD(19)). Mutating D(19) to A(19) abrogated AP-2alpha cleavage by all three caspases. TNF-alpha-induced cleavage of AP-2alpha in vivo led to AP-2alpha degradation and loss of DNA-binding activity, both of which were prevented by pretreatment with zVEIDfmk. AP-2alpha degradation but not cleavage was inhibited in vivo by PS-431 (a proteasome antagonist), suggesting that AP-2alpha is degraded subsequent to cleavage by caspase 6 or caspase 6-like enzymes. Cells transfected with green fluorescent protein-tagged mutant AP-2alpha are resistant to TNF-alpha-induced apoptosis, further demonstrating the link between caspase-mediated cleavage of AP-2alpha and apoptosis. This is the first report to demonstrate that degradation of AP-2alpha is a critical event in TNF-alpha-induced apoptosis. Since the DRHD sequence in vertebrate AP-2 is widely conserved, its cleavage by caspases may represent an important mechanism for regulating cell survival, proliferation, differentiation, and apoptosis.
多项报告已将激活蛋白2α(AP - 2α)与细胞凋亡联系起来,这使我们推测AP - 2α是半胱天冬酶的底物。我们通过研究肿瘤坏死因子α(TNF - α)对乳腺癌细胞中AP - 2表达的影响来验证这一假设。在此,我们提供证据表明,在TNF - α诱导的细胞凋亡过程中,TNF - α在转录后下调AP - 2α和AP - 2γ的表达。一种通用的半胱天冬酶拮抗剂(zVADfmk)和一种半胱天冬酶6优先拮抗剂(zVEIDfmk)均抑制TNF - α诱导的细胞凋亡和AP - 2α下调。体内试验表明,在细胞凋亡的DNA片段化阶段之前,AP - 2α被半胱天冬酶切割。重组半胱天冬酶6优先切割AP - 2α,尽管半胱天冬酶1和3也能切割它,不过需要50倍或更高的浓度。在TNF - α处理的细胞中检测到活化的半胱天冬酶6,从而证实其参与了AP - 2α的切割。所有三种半胱天冬酶均在天冬氨酸 - 精氨酸 - 组氨酸 - 天冬氨酸(DRHD(19))序列的天冬氨酸(19)处切割AP - 2α。将D(19)突变为A(19)可消除所有三种半胱天冬酶对AP - 2α的切割。TNF - α在体内诱导的AP - 2α切割导致AP - 2α降解和DNA结合活性丧失,而这两者都可通过zVEIDfmk预处理来预防。PS - 431(一种蛋白酶体拮抗剂)在体内抑制了AP - 2α的降解但未抑制其切割,这表明AP - 2α在被半胱天冬酶6或类似半胱天冬酶6的酶切割后会被降解。用绿色荧光蛋白标记的突变型AP - 2α转染的细胞对TNF - α诱导的细胞凋亡具有抗性,这进一步证明了半胱天冬酶介导的AP - 2α切割与细胞凋亡之间的联系。这是第一份证明AP - 2α降解是TNF - α诱导的细胞凋亡中的关键事件的报告。由于脊椎动物AP - 2中的DRHD序列广泛保守,其被半胱天冬酶切割可能代表了一种调节细胞存活、增殖、分化和凋亡的重要机制。